Nanotechnology also offers promising therapeutic options for Alzheimer's disease. Nanocarriers such as liposomes, dendrimers, and polymeric nanoparticles can be used to deliver drugs directly to the brain, crossing the blood-brain barrier more effectively than conventional methods. These nanocarriers can be engineered to release the drug in a controlled manner, increasing the treatment's efficacy and reducing side effects.
